Petrus Trust Company’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-665
Closed -$203K 639
2025
Q1
$203K Buy
+665
New +$224K 0.02% 540
2024
Q4
Sell
-1,095
Closed -$366K 677
2024
Q3
$366K Sell
1,095
-386
-26% -$147K 0.04% 340
2024
Q2
$610K Buy
1,481
+567
+62% +$225K 0.06% 154
2024
Q1
$369K Buy
+914
New +$321K 0.03% 346
2023
Q2
Sell
-1,259
Closed -$237K 685
2023
Q1
$237K Buy
+1,259
New +$260K 0.03% 407
2018
Q4
Sell
-4,394
Closed -$263K 275
2018
Q3
$263K Buy
+4,394
New +$240K 0.06% 130

Other funds holding MEDP

Petrus Trust Company's MEDP Position: Q2 2025 in Review

Petrus Trust Company sold out of Medpace (MEDP) in Q2 2025, closing a stake of 665 shares — an estimated $203K sold.

Petrus Trust Company first reported a position in MEDP in Q3 2018 and held it in 6 quarters. The position peaked at $610K in Q2 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Petrus Trust Company reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Petrus Trust Company sold 665 Medpace shares in Q2 2025, an estimated $203K.
  • Petrus Trust Company first reported a position in Medpace in Q3 2018 and held it in 6 quarters.
  • Petrus Trust Company's Medpace position peaked at $610K in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Petrus Trust Company's 13F filing for Q2 2025, filed 14 Aug 2025.